Author

Zbignew K. Wszolek

Mayo Clinic in Florida

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Dennis W. DicksoniD· 2 shared E. Richard StanleyiD· 2 shared Fabrizio BiundoiD· 2 shared Gabriel G. L. Shlager· 2 shared Harmony C. Ketchum· 2 shared Michael A. DetureiD· 2 shared Violeta ChiţuiD· 2 shared Andrew L. CroxfordiD· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Dennis W. DicksonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintFeb 21, 2022

Granulocyte Colony Stimulating Factor causes cerebellar deficits and anxiety in a mouse model of CSF-1 receptor-related leukoencephalopathy

Fabrizio Biundo, Violeta Chiţu, Jaafar O. Tindi…·E. Richard Stanley

This study shows that reducing Csf3 in Csf1r+/- mice improves anxiety, motor coordination, and social interaction but not cognitive deficits, and reduces microglial activation in the cerebellum.

DOI 10.1101/2022.02.21.481325

mouseexperimental assay

𝕏 PostBluesky

NeurosciencebioRxivDec 23, 2019

Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signaling

Violeta Chiţu, Fabrizio Biundo, Gabriel G. L. Shlager…·E. Richard Stanley

This study shows that reducing CSF-2 in Csf1r+/- mice rescues behavioral and histopathological deficits in ALSP by preventing microgliosis and transcriptomic changes, suggesting CSF-2 as a therapeutic target.

DOI 10.1016/j.celrep.2020.02.028

mousehuman

𝕏 PostBluesky